Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia

被引：7
|
作者：
Wei, Hui [1 ,2 ,3 ,4 ]
Zhou, Chunlin [3 ,4 ]
Lin, Dong [3 ,4 ]
Liu, Bingcheng [3 ,4 ]
Li, Yan [3 ,4 ]
Zhao, Xingli [3 ,4 ]
Wei, Shuning [3 ,4 ]
Gong, Benfa [3 ,4 ]
Liu, Kaiqi [3 ,4 ]
Gong, Xiaoyuan [3 ,4 ]
Liu, Yuntao [3 ,4 ]
Zhang, Guangji [3 ,4 ]
Chen, Jiayuan [1 ]
Zhang, Junping [3 ,4 ]
Jin, Jingjing [3 ,4 ]
Qiu, Shaowei [3 ,4 ]
Gu, Runxia [3 ,4 ]
Wang, Ying [2 ,3 ,4 ]
Mi, Yingchan [1 ,2 ,3 ,4 ]
Wang, Jianxiang [1 ,2 ,3 ,4 ]
机构：
[1] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Inst Hematol, Natl Clin Res Ctr Blood Dis, Tianjin, Peoples R China
[3] Chinese Acad Med Sci, Inst Hematol, Leukemia Ctr, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 05期
基金：
中国国家自然科学基金;
关键词：
RANDOMIZED-TRIAL; ADULTS; DAUNORUBICIN; AML;
D O I：
10.3324/haematol.2020.267526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1491 / 1495
页数：5
相关论文
共 50 条
  • [31] Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics
    Zhou, Ji-hao
    Lin, Hai-qing
    Shen, Qi
    Hu, Li-na
    Li, Guo-qiang
    Sun, Xiong-fei
    Zhang, Xin-you
    CURRENT MEDICAL SCIENCE, 2018, 38 (01) : 51 - 57
  • [32] Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics
    周继豪
    林海清
    沈琦
    胡丽娜
    李国强
    孙雄飞
    张新友
    Current Medical Science, 2018, (01) : 51 - 57
  • [33] Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics
    周继豪
    林海清
    沈琦
    胡丽娜
    李国强
    孙雄飞
    张新友
    Current Medical Science, 2018, 38 (01) : 51 - 57
  • [34] Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
    Trifilio, Steven M.
    Rademaker, Alfred W.
    Newman, Diane
    Coyle, Katherine
    Carlson-Leuer, Katrin
    Mehta, Jayesh
    Altman, Jessica
    Frankfurt, Olga
    Tallman, Martin S.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 394 - 396
  • [35] TREATMENT OF ACUTE MYELOID-LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE
    BRITOBABAPULLE, F
    CATOVSKY, D
    NEWLAND, AC
    GOLDMAN, JM
    GALTON, DAG
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 51 - 52
  • [36] IDARUBICIN IN COMBINATION WITH INTERMEDIATE-DOSE CYTARABINE AND VP-16 IN THE TREATMENT OF REFRACTORY OR RAPIDLY RELAPSED PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    CARELLA, AM
    CARLIER, P
    PUNGOLINO, E
    RESEGOTTI, L
    LISO, V
    STASI, R
    MONTILLO, M
    IACOPINO, P
    MIRTO, S
    PAGANO, L
    LEONI, F
    MARTELLI, FM
    DIRAIMONDO, F
    PORCELLINI, A
    DERIU, L
    NOSARI, AM
    CIMINO, R
    DAMASIO, E
    MIRAGLIA, E
    FIORITONI, G
    RICCIUTI, F
    CAROTENUTO, M
    LONGINOTTI, M
    DEFAZIO, D
    FAZI, P
    MANDELLI, F
    LEUKEMIA, 1993, 7 (02) : 196 - 199
  • [37] Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia
    Lee, Sung-Sook
    Lee, Je-Hwan
    Lee, Jung-Hee
    Kim, Dae-Young
    Kim, Se Hyung
    Lim, Sung-nam
    Lee, Young-Shin
    Seol, Miee
    Ryu, Seong-Gil
    Kang, Young-Ah
    Jang, Seongsoo
    Park, Chan-Jeoung
    Chi, Hyun-Sook
    Yun, Sung-Cheol
    Lee, Kyoo-Hyung
    LEUKEMIA RESEARCH, 2009, 33 (04) : 511 - 517
  • [38] Cytarabine Dose for Acute Myeloid Leukemia REPLY
    Lowenberg, Bob
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2168 - 2169
  • [39] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    BLOOD, 1996, 87 (05) : 1710 - 1717
  • [40] Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia
    Reman, O
    Buzyn, A
    Lhéritier, V
    Huguet, F
    Kuentz, M
    Stamatoullas, A
    Delannoy, A
    Fegueux, N
    Micléa, JM
    Boiron, JM
    Vernant, JP
    Gardin, C
    Hacini, M
    Georges, M
    Fière, D
    Thomas, X
    HEMATOLOGY JOURNAL, 2004, 5 (02) : 123 - 129
12345